Letter to the EditorPericardial effusion as primary manifestation of Takayasu arteritis
Section snippets
Case report
A 32-year-old woman was admitted for diagnostic pericardiocenthesis.
Her medical history began with backpain, fatigue, malaise, fever and adynamia 6 months ago. Blood tests showed increased C-reactive protein (CRP) and normochrome and normocytic anemia. The patient was presented to an orthopaedic specialist who did not find any cause for her backpain.
Chest X-ray was taken 5 months after onset of symptoms, showing cardiomegaly. An external cardiologist documented pericardial effusion and referred
Discussion
TA is a chronic primary vasculitis of unknown etiology [1], affecting young women in 80–90% of cases with greatest prevalence in Asians. Early diagnosis of TA is extremely difficult, because all symptoms in the early phase such as fatigue, low-grade fever, malaise, arthralgia and a loss of body weight are all non-specific [2]. At this early phase, vascular changes may not be sufficiently advanced, hence the specific symptoms like cold extremities, claudication or blood pressure differences may
Acknowledgements
The authors of this manuscript have certified that they comply with the Principles of Ethical Publishing in the Journal of Cardiology [10].
References (10)
- et al.
Systemic manifestations of Takayasu arteritis: the expanding spectrum
Int J Cardiol
(1996) - et al.
What is the best approach to diagnosing large-vessel vasculitis?
Best Practice Res Clin Rheumatol
(2005) - et al.
Takayasu's arteritis. Clinical study of 107 cases
Am Heart J
(1977) - et al.
Pulmonary artery involvement as first manifestation in three cases of Takayasu's arteritis
Int J of Cardiol
(1996) Ethical authorship and publishing
Int J Cardiol
(2009)
Cited by (15)
Takayasu's Arteritis
2017, The Heart in Rheumatic, Autoimmune and Inflammatory Diseases: Pathophysiology, Clinical Aspects and Therapeutic ApproachesThe Heart in Vasculitis
2014, Rheumatic Disease Clinics of North AmericaCitation Excerpt :Arterial or venous pulmonary hypertension is generally mild to moderate, therefore, rarely leads to right ventricular failure.28 Pericarditis occurs in about 8% of the subjects with TAK,7 generally as part of a febrile syndrome, and sometimes as the initial manifestation of the disease.29 Treatment of pericardial inflammation includes nonsteroidal anti-inflammatory drugs (NSAIDs) or moderate doses of CS.
Recurrent acute pericarditis in Takayasu arteritis
2013, International Journal of CardiologyA case of Takayasu arteritis complicated with acute pericarditis at initial presentation
2023, Modern Rheumatology Case ReportsNovel Therapies in Takayasu Arteritis
2022, Frontiers in Medicine